BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Return on equity
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to BCLISource: SEC XBRL filings · For reference only · Not investment advice
More BCLI financial trends
BCLI RevenueBCLI Net incomeBCLI Net marginBCLI Gross profitBCLI Gross marginBCLI Operating incomeBCLI Operating marginBCLI Operating cash flowBCLI Free cash flowBCLI Capital expendituresBCLI Stock buybacksBCLI Dividends paidBCLI Total assetsBCLI Total liabilitiesBCLI Shareholders’ equityBCLI overview →